Abstract
The resin of the frankincense tree contains therapeutically effective boswellic acids (BA), which selectively inhibit the synthesis of Leucotrienes (LT). The inflammatory and pain cascade is interrupted without significant side effects. Even on the basis of long-term intake, the initial effects are maintained. Indications for a frankincense therapy are all chronic inflammatory and allergic diseases. Complementary oncology is a possible application area. In vitro studies show that at higher concentrations BA inhibited the proliferation of tumour cells, possibly by inducing programmed cell death (apoptosis) of malignant cells. Based on clinical experience, the treatment of patients having tumor induced oedema derived from brain tumors (astrocytoma, glioblastoma) and brain metastases with frankincense, have revealed impressive results. Peri-tumoural brain oedemas are generally suppressed employing glucocorticosteroides that can cause substantial side effects leading to further chronic illnesses especially after long-term application.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
